Shams Tabrez
Impact in
- Molecular Medicine top 2%
Papers in
-
- Advanced Glycation End Products research 12
- Co-authors
- Nasimudeen R. JabirMasood AhmadMohammad Amjad KamalTorki A. ZughaibiShazi ShakilMohd Shahnawaz KhanSamina WasiMohd Suhail
- Journals
- CNS & Neurological Disorders - Drug Targets (13 papers)Current Pharmaceutical Design (9 papers)Saudi Journal of Biological Sciences (9 papers)Journal of Cellular Biochemistry (8 papers)Current Drug Metabolism (5 papers)
- Partner nations
- Saudi ArabiaIndiaUnited States
In The Last Decade
Shams Tabrez
218 papers receiving 6.1k citations
Hit Papers
Peers
Comparison fields: 5 of 159
- Molecular Medicine 276
- Complementary and alternative medicine 418
- Clinical Biochemistry 332
- Biochemistry 278
- Pharmacology 646
Countries citing papers authored by Shams Tabrez
This map shows the geographic impact of Shams Tabrez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shams Tabrez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shams Tabrez more than expected).
Fields of papers citing papers by Shams Tabrez
This network shows the impact of papers produced by Shams Tabrez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shams Tabrez. The network helps show where Shams Tabrez may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shams Tabrez, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | STAT3 Signaling Pathway in Health and Disease Hit paper breakdown → | 2025 | 29 |
| 3 | 2024 | 5 | |
| 4 | 2024 | 3 | |
| 5 | 2024 | 3 | |
| 6 | 2023 | 22 | |
| 7 | 2023 | 12 | |
| 8 | 2023 | 15 | |
| 9 | 2023 | 47 | |
| 10 | 2022 | 62 | |
| 11 | 2022 | 15 | |
| 12 | 2022 | 19 | |
| 13 | 2022 | 37 | |
| 14 | 2022 | 20 | |
| 15 | 2021 | 37 | |
| 16 | 2020 | 37 | |
| 17 | 2020 | 29 | |
| 18 | 2018 | 5 | |
| 19 | 2017 | 2 | |
| 20 | 2014 | 56 |
About Shams Tabrez
Shams Tabrez is a scholar working on Toxicology, Clinical Biochemistry, Molecular Medicine, Pharmacology and Health, Toxicology and Mutagenesis, having authored 227 papers that have together received 6.2k indexed citations. Recurring topics across this work include Computational Drug Discovery Methods (20 papers), Research on Leishmaniasis Studies (18 papers), Cholinesterase and Neurodegenerative Diseases (18 papers), Alzheimer's disease research and treatments (14 papers), Natural Antidiabetic Agents Studies (12 papers), Advanced Glycation End Products research (12 papers), Nanoparticles: synthesis and applications (11 papers) and Carcinogens and Genotoxicity Assessment (11 papers). The work is most often cited by research in Molecular Medicine (276 citations), Complementary and alternative medicine (418 citations), Clinical Biochemistry (332 citations), Biochemistry (278 citations) and Pharmacology (646 citations). Shams Tabrez has collaborated with scholars based in Saudi Arabia, India and United States. Frequent co-authors include Nasimudeen R. Jabir, Masood Ahmad, Mohammad Amjad Kamal, Torki A. Zughaibi, Shazi Shakil, Mohd Shahnawaz Khan, Samina Wasi, Mohd Suhail, Syed Kashif Zaidi and Adel Abuzenadah. Their work appears in journals such as CNS & Neurological Disorders - Drug Targets, Current Pharmaceutical Design, Saudi Journal of Biological Sciences, Journal of Cellular Biochemistry and Current Drug Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.